Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-02-26 @ 5:45 PM
Study NCT ID:
NCT00797667
Status:
TERMINATED
Last Update Posted:
2018-10-18
First Post:
2008-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2009-05-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05-20
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-24
First Submit QC Date:
None
Study First Post Date:
2008-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-13
Results First Submit QC Date:
None
Results First Post Date:
2014-09-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-21
Last Update Post Date:
2018-10-18
Last Update Post Date Type:
ACTUAL